3 Minute Read
Regulatory Market Update Updates for Pharma Manufacturers As always, if you have questions on any of the content found in this or previous market updates, please reach out to...
6 Minute Read
Market access leaders from DBV Technologies, Karyopharm Therapeutics, and Sesen Bio discuss critical factors in a successful launch and ways to achieve pre-launch forecasts.
4 Minute Read
In his second unification-focused blog, President and COO Josh Halpern discusses IntegriChain's investment in customer support to better augment the value for customers and end-users.
5 Minute Read
Solutions to common challenges that manufacturers face when commercializing rare and orphan disease therapies.
5 Minute Read
And other regulatory updates on Line Extension guidance, the upcoming DUNS number transition, and emergency 340B flexibilities.
4 Minute Read
President and COO Josh Halpern discusses the current and future capabilities of the integrated applications, analytics, and datastores within the ICyte Platform.
2 Minute Read
How manufacturers can leverage successful returns and inventory pipeline reserve methodologies for long-term benefits.
4 Minute Read
Potential and pending regulatory changes in 2022 including the current status of the Build Back Better Act and Part D Benefit Design.
2 Minute Read
Our newly combined team of commercialization experts focuses on solving your biggest access challenges: patient funnel pull-through and GTN optimization.